Sunday, February 24, 2019

BioInvent Financial Statement January 1 - December 31, 2018

LUND, Sweden, Feb. 25, 2019 /PRNewswire/ -- Fourth quarter 2018, October – December Net sales amounted to SEK 10.4 (13.5) million. Loss after tax SEK -32.7 (-33.3) million. Loss after tax per share before and after dilution SEK -0.09 (-0.11). Cash flow from operating activities and...



from PR Newswire: https://ift.tt/2TdUCwL

No comments:

Post a Comment